Funding Rounds
iOnctura

iOnctura Series B (2024, $85M)

iOnctura

Clinical-stage biotechnology developing treatments for cancer.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $85.50M

Investors